Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
Summary
This is a multicenter, randomized, placebo-controlled study to evaluate the effectiveness and safety of low-dose aspirin (50 mg/day) in renal and cardiac function protection in people with diabetic nephropathy.
Official title: A Phase III Multi-center Randomized Placebo-controlled Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
355
Start Date
2024-01-01
Completion Date
2027-06-30
Last Updated
2023-10-05
Healthy Volunteers
No
Conditions
Interventions
Acetylsalicylic Acid
aspirin 50 mg/d to be taken after dinner (in nonfasting conditions)
Placebo
Placebo 50 mg/d to be taken after dinner (in nonfasting conditions)